Book contents
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- 165 Mycoplasma
- 166 Chlamydia Pneumoniae
- 167 Chlamydia Psittaci (Psittacosis)
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
167 - Chlamydia Psittaci (Psittacosis)
from Part XX - Specific Organisms – Mycoplasma and Chlamydia
Published online by Cambridge University Press: 05 March 2013
- Frontmatter
- Contents
- Preface
- Contributors
- Part I Clinical Syndromes – General
- Part II Clinical Syndromes – Head and Neck
- Part III Clinical Syndromes – Eye
- Part IV Clinical Syndromes – Skin and Lymph Nodes
- Part V Clinical Syndromes – Respiratory Tract
- Part VI Clinical Syndromes – Heart and Blood Vessels
- Part VII Clinical Syndromes – Gastrointestinal Tract, Liver, and Abdomen
- Part VIII Clinical Syndromes – Genitourinary Tract
- Part IX Clinical Syndromes – Musculoskeletal System
- Part X Clinical Syndromes – Neurologic System
- Part XI The Susceptible Host
- Part XII HIV
- Part XIII Nosocomial Infection
- Part XIV Infections Related to Surgery and Trauma
- Part XV Prevention of Infection
- Part XVI Travel and Recreation
- Part XVII Bioterrorism
- Part XVIII Specific Organisms – Bacteria
- Part XIX Specific Organisms – Spirochetes
- Part XX Specific Organisms – Mycoplasma and Chlamydia
- 165 Mycoplasma
- 166 Chlamydia Pneumoniae
- 167 Chlamydia Psittaci (Psittacosis)
- Part XXI Specific Organisms – Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific Organisms – Fungi
- Part XXIII Specific Organisms – Viruses
- Part XXIV Specific Organisms – Parasites
- Part XXV Antimicrobial Therapy – General Considerations
- Index
Summary
Chlamydophila psittaci was identified simultaneously by three investigators in 1930. It is one of four species within the genus Chlamydia. Based on RNA sequencing, it is currently considered distinct from Chlamydophila pneumoniae and Chlamydia trachomatis, despite phenotypic and physiologic similarities that have taxonomically bound them for many years. The organism is an obligate intracellular pathogen that contains both RNA and DNA but lacks a classic cell wall. These characteristics contribute to both the clinical manifestations as well as determine therapeutic options. Chlamydophila psittaci has a wide range of host species, including birds, humans, and lower mammals. Chlamydophila pneumoniae, however, is found only in humans, and Chlamydia trachomatis only in humans and mice.
The systemic illness associated with C. psittaci has been termed psittacosis because of its association with parrots and psittacine birds. Subsequently, many avian species have been found to harbor C. psittaci and to transmit the organism to humans, causing disease. The term ornithosis would be more appropriate; however, it is not traditional. The organism can be carried for years in birds, remaining latent causing disease many years after acquisition. Transmission to humans can occur even in the absence of disease in the bird. Excretion in the feces with aerosolization is the typical mode of transmission. Human-to-human transmission has been documented rarely and usually in the setting of severe disease. Health care workers have acquired the disease, but it is not felt warranted to isolate patients when hospitalized.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 1161 - 1164Publisher: Cambridge University PressPrint publication year: 2008